Skip to main content

Prostate specific antigen level after 3months of androgen deprivation therapy can predict overall survival in patients with metastatic hormone-sensitive prostate cancer.

Park
Kyung Kgi
Urology
Jeju National university
Jeju
South korea
Show all authors
Huh
Jung Sik
Urology
Jeju National university
Jeju
South korea

Tabs

Speciality: 
Oncology (medical)
Keywords: 
Androgen deprivation therapy, Prostate specific antigen, Prostate cancer, overall survival